UPDATE: Baird Downgrades Arcturus Therapeutics (ARCT) to Neutral; 'Underwhelming ARCT-021 Phase 1/2 Data'
Tweet Send to a Friend
(Updated - December 29, 2020 7:17 AM EST)
(updated to add analyst comments)Baird analyst Madhu Kumar downgraded Arcturus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Baird analyst Madhu Kumar downgraded Arcturus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
